GL1X · GenesisL1 explorer

MolNFT v1 · #96640 · protein

Structure of shv-1 beta-lactamase in complex with the 7- alkylidenecephalosporin dcm-1-10 at 1.14 ang resolution

4JPM · Beta-lactamase shv-1: “Structure of shv-1 beta-lactamase in complex with the 7- alkylidenecephalosporin dcm-1-10 at 1.14 ang…”. X-ray diffraction, 2 ligands (MA4, 1OG), 2 pockets (best druggability 0.69). MolNFT v1 #96640 on…

PDB
4JPM
Type
protein
Length
265 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Beta-lactamase shv-1
EC
3.5.2.6
UniProt
P0AD64
Ligands
MA4, 1OG
Pockets
2 · best druggability 0.69

Structure

x-ray diffraction · 1 distinct chain · 45% helix, 17% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ABeta-lactamase shv-1 (EC 3.5.2.6)protein26545% helix, 17% strandP0AD64

Ligands and binding sites

  • MA4 · Cyclohexyl-hexyl-beta-D-maltoside · ligand · 2 copies · chains A
  • 1OG · 7-alkylidenecephalosporin DCM-1-10, bound form · ligand · chains A
  • EPE · 4-(2-hydroxyethyl)-1-piperazine ethanesulfonic acid · additive · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12070.690.8623MA4
2510.270.75151OG, EPE

Modifications

Observed in the structure: 1 covalent, 1 disulfide (covalent ligand, disulfide).

Compared structures

  • 4JPM · Structure of SHV-1 beta-lactamase in complex with the 7-alkylidenecephalosporin DCM-1-10… · the same entry in another collection · chain A against A, TM-score 1.00
  • P0AD64 · AlphaFold monomer V2.0 prediction for beta-lactamase shv-1 (P0AD64) · a predicted model of the same protein · chain A against A, TM-score 0.98

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.